title: Commentary: Omalizumab therapy for bullous pemphigoid by KK Yu, AB Crew, KAN Messingham, JA Fairley, DT Woodley. J Am Acad Dermatol 2014 Jun 20. pii: S0190-9622(14)01410-8. doi: 10.1016/j.jaad.2014.04.053. [Epub ahead of print].
authors.affiliation: Department of Dermatology, University of Texas Southwestern Medical Center in Dallas, Dallas, Texas, USA.
authors.forename: Kim B
authors.initials: KB
authors.lastname: Yancey
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010391:Pemphigoid, Bullous / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized